National Institute on Drug Abuse; Notice of Closed Meeting

• Published date: 23 January 2019
• Citation: 84 FR 224
• Record Number: 2019-00087
• Section: Notices
• Court: Health And Human Services Department,National Institutes Of Health

Federal Register, Volume 84 Issue 15 (Wednesday, January 23, 2019)

[Federal Register Volume 84, Number 15 (Wednesday, January 23, 2019)]
                [Notices]
                [Page 224]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2019-00087]
                ========================================================================
                Notices
                 Federal Register
                ________________________________________________________________________
                This section of the FEDERAL REGISTER contains documents other than rules
                or proposed rules that are applicable to the public. Notices of hearings
                and investigations, committee meetings, agency decisions and rulings,
                delegations of authority, filing of petitions and applications and agency
                statements of organization and functions are examples of documents
                appearing in this section.
                ========================================================================
                Federal Register / Vol. 84, No. 15 / Wednesday, January 23, 2019 /
                Notices
                [[Page 224]]
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                National Institutes of Health
                National Institute on Drug Abuse; Notice of Closed Meeting
                 Pursuant to section 10(d) of the Federal Advisory Committee Act, as
                amended, notice is hereby given of the following meeting.
                 The meeting will be closed to the public in accordance with the
                provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
                U.S.C., as amended. The contract proposals and the discussions could
                disclose confidential trade secrets or commercial property such as
                patentable material, and personal information concerning individuals
                associated with the contract proposals, the disclosure of which would
                constitute a clearly unwarranted invasion of personal privacy.
                 Name of Committee: National Institute on Drug Abuse Special
                Emphasis Panel; Health IT to Combat Opioid Misuse (1225).
                 Date: January 31, 2019.
                 Time: 8:00 a.m. to 5:30 p.m.
                 Agenda: To review and evaluate contract proposals.
                 Place: National Institutes of Health, Neuroscience Center, 6001
                Executive Boulevard, Rockville, MD 20852 (Telephone Conference
                Call).
                 Contact Person: Julia Berzhanskaya, Ph.D., Scientific Review
                Officer, Office of Extramural Policy and Review, Division of
                Extramural Research, National Institute on Drug Abuse, NIH, DHHS,
                6001 Executive Boulevard, Room 4234, MSC 9550, Bethesda, MD 20892,
                301-827-5840, julia.berzhanskaya@nih.gov.
                 This meeting notice is being published less than 15 days in
                advance of the meeting due to the partial Government shutdown of
                December 2018.
                (Catalogue of Federal Domestic Assistance Program No.: 93.279, Drug
                Abuse and Addiction Research Programs, National Institutes of
                Health, HHS)
                 Dated: January 17, 2019.
                Natasha M. Copeland,
                Program Analyst, Office of Federal Advisory Committee Policy.
                [FR Doc. 2019-00087 Filed 1-22-19; 8:45 am]
                 BILLING CODE 4140-01-P